Nippon India Nifty Pharma ETF - Growth Plan vs Motilal Oswal Developed Market Ex US Etfs Fund of Funds - Direct Plan - Growth
NAV, returns and costs — not a recommendation.
 Nippon India Nifty Pharma ETF - Growth Plan |  Motilal Oswal Developed Market Ex US Etfs Fund of Funds - Direct Plan - Growth | |
|---|---|---|
| NAV | ₹27.1122 | ₹19.0154 |
| NAV date | 2026-08-18 | 2026-08-18 |
| 1 year | +19.49% | +32.54% |
| 3 year (p.a.) | +20.35% | +25.45% |
| 5 year (p.a.) | +14.55% | +25.45% |
| Expense ratio | 0.18% | 0.04% |
| Fund size | ₹1,622.31 Cr | ₹38.27 Cr |
| Risk | Very high | — |
| Category | Etfs | Fund of Funds Overseas |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.